NAT-DONEPEZIL Comprimé

Страна: Канада

Язык: французский

Источник: Health Canada

Активный ингредиент:

Chlorhydrate de donépézil

Доступна с:

NATCO PHARMA (CANADA) INC

код АТС:

N06DA02

ИНН (Международная Имя):

DONEPEZIL

дозировка:

5MG

Фармацевтическая форма:

Comprimé

состав:

Chlorhydrate de donépézil 5MG

Администрация маршрут:

Orale

Штук в упаковке:

7/14/28/30/100

Тип рецепта:

Prescription

Терапевтические области:

PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS

Обзор продуктов:

Numéro de groupe d'ingrédients actifs (GIA) :0131548001; AHFS:

Статус Авторизация:

APPROUVÉ

Дата Авторизация:

2015-05-27

Характеристики продукта

0R RJDSLHGH1 7
R HSH LO
3DJH
GH
0212*53+,('(352'8,7
3U
17 '21(3(=,/
RPSULPpVGHFKORUKGUDWHGHGRQpSp]LO
PJ HW PJ
83
,QLELHXU GHOD FROLQHVpUDVH
'DWHGHUpYLVLRQ
IpYULHU
1DWFR3KDUPD
DQDGD ,QF
UJHQWLD5RDG3OD]D VXLWH
0LVVLVVDXJD 2QWDULR
/1 3
1XPpURGH FRQWUOH
0R RJDS LH GH 1 7
R HSH LO
3DJH
GH
7DEOHGHVPD LqUHV
357,( ,
5(1(,*1(0(17 3285/(352)(
,211(/'( /
17e
5(16(,*1(0(1766200,5(6 685/(352'8,7
,1',
7,216(7 86 *(/,1,48(
2175( ,1',
7,216
0,6(6 (1*5'((7 35e 87,216
())(76 ,1'e6,5 %/(6
,17(5
7,2160e', 0(17(86(6
3262/2*,((7 02'(' '0,1,6757,21
685'26
*(
02'('
7,21(73+502/2*,(/,1,48(
67 %,/,7e (7
216(597,21
35e6(177,2120326,7,21(7
21',7,211(0(17
357,( ,, 5(1(,*1(0(17
,(17,),48(
5(16(,*1(0(176 3+ 50
(87,48(6
3+ 50
2/2*,('e7 ,//e(
72;,2/2*,(
%,%/,2*53+,(
357,( ,,,
5(1(,*1(0(17 3285/(212007(85
0R RJDSLHGH1 7
R HSH LO
3DJH
GH
3U
17 '21(3(=,/
RPSULPpVGHFKORUKGUDWHGHGRQpSp]LO 863
357,(, 5(1(,*1(0(17 3285/(352)(
,211(/ '(/
17e
5(1(,*1(0(17
200,5(
85/(352'8,7
RLH
GDGPLQLV UDLRQ
3UpVHQD LRQH
HQHXU
( FLSLHQVGLPSRUDQFHFOLQLTXH
2UDOH
RPSULPp GRVpj
PJ HWj
PJ
0RQRKGUDWH GH ODFWRVH DPLGRQ GH
GHPDwV
K GUR[SURSO FHOOXORVH
IDLEOHPHQW VXEVWLWXpHFHOOXORVH
PLFURFULVWDOOLQHVWpDUDWHGH
PDJQpVLXPKSURPHOORVH
SRO
pWKOqQHJO
FROGLR[GHGH
WLWDQH HW OHWDOF(Q RXWUHOHFRPSULPp
FRQWLHQW
PJGH MDXQHGR[GHGH
IHUFRPPHDJHQWGHFRORUDWLRQ
,1',7,21 (78*(
/,1,48(
17 'RQHSH]LO HVWLQGLTXpSRXU
OH WUDLWHPHQW VPSWRPDWLTXHGHOD GpPHQFHGHWSH
O]KHLPHUG LQWHQVLWpOpJqUHPRGpUpHHW
VpYqUH
/HIILFDFLWpGHFKORUKGUDWH GHGRQpSp]LOFKH]OHVSDWLHQWV DWWHLQWV G
DO]KHLPHU OpJHURXPRGpUp
DpWppWDEOLHDXPRHQ GH
pWXGHV FOLQLTXHVFRPSDUDWLYHVDYHFSODFHER GH
VHPDLQHVHW
GXQHDXWUH GHVHPDLQHV6RQHIILFDFLWpFKH]OHVSDWLHQWV DWWHLQWV G
DO]KHLPHUVpYqUHDpWp
pWDEOLH GDQVOHFDGUHGH
pWXGHV FOLQLTXHV FRPSDUDWLYHVDYHFSODFHERGH
VHPDLQHV
PRLV
/HWUDLWHPHQW SDU OHV FRPSULPpV17 'RQHSH]LO GHYUDLWrWUHSUHVFULW SDU
XQSUDWLFLHQ
H[SpULPHQWp GDQV OH GLDJQRVWLFHWOHWUDLWHPHQWGH ODPDODGLH G
O]KHLPHURXDSUqV
FRQVXOWDWLRQG XQWHOVSpFLDOLVWH
2175( ,1', 7,21
17 'RQHSH]LO HVWFRQWUH LQGLTXp FKH]OHV SDWLHQWV KSHUVHQVLEOHV
jFHSURGXLW RX j G DXWUHV
GpULY